The global parenteral nutrition market was valued at USD 6,018.4 Million in 2020 and is expected to reach a value of USD 9,158.7 Million by 2030, and register a CAGR of 5.3% during the forecast period. Increasing number of malnourished children, especially in developing and underdeveloped countries, increasing incidence of premature births, high prevalence of various types of cancer are factors resulting in need to administration of parenteral nutrition for patients who cannot eat through tube feeding or by mouth. These factors are expected to drive demand and adoption of parenteral nutrition, thereby driving market growth.
Parenteral nutrition, abbreviated as PN, is an intravenous administration of vital nutrition. These nutrients include protein, fat, carbohydrate, electrolytes, minerals, vitamins, and crucial trace elements. Increasing number of geriatric population, and need for administering vital nutrients to maintain hydration levels, energy, and strength of patients is one of the key factors driving market growth.
Increasing prevalence of chronic diseases such as various types of cancers results in low energy levels, and no appetite, which is expected to result in higher demand for parenteral nutrition, thereby driving growth of the global parenteral nutrition market. Increasing number of premature births, as well as the scarcity of essential nutrients in premature infants and newborns, are factors expected to drive adoption of intravenous administration of nutrition, especially in developing and underdeveloped countries of Asia Pacific and Africa. Growing initiatives by government and non-government organizations, such as the National Association of Nutrition Professionals, the American Association, the American Society for Parenteral and Enteral Nutrition, and many others, are raising awareness about diet are factors expected to support market growth.
Request a Sample@ https://qyresearchmedical.com/sample/119001
Adequate and timely parenteral nutrition can help fight complications and can be helpful in faster patient recovery. It is mainly administered to patients with diseases or conditions affecting food intake, digestion or absorption of nutrients, short bowel syndrome, gastrointestinal fistulas, intestinal obstruction, critically ill patients, and severe acute pancreatitis. According to a 2014 survey, number of patients that received parenteral nutrition in more than 290,000 during their hospital stays, out of which, 43% were children and newborns. In addition, the ease of use has allowed patients to receive parenteral nutrition even at home. It is estimated that approximately more 25,000 patients received parenteral nutrition at home. These are factors expected to drive market growth to a significant extent.
Lack of awareness and possible side effects associated with parenteral nutrition such as changes in heart rate, seizures, rapid weight gain or loss, fatigue, fever or chills, increased urination, and memory loss are factors that could hamper growth of the global parenteral nutrition market.
Nutrient Type Outlook:
The single dose amino acid solutions segment accounted for major revenue share in the global parenteral nutrition market in 2020, due to growing awareness regarding health and fitness among people, and high prevalence of chronic diseases globally. One of the most important aspects of PN provision is effective monitoring and its review. It is recommended to include vital signs, blood glucose, fluid balance and blood and urine biochemistry as routine monitoring. The complications associated with parenteral nutrition can be avoided with proper care guidelines regarding its administration process.
The lipid emulsion segment is expected to register the highest growth rate during the forecast period, followed by the carbohydrates segment by registering second highest revenue growth rate, due to its potential advantages as a drug carrier in the whole body. PN can lead to agony, aggravation leading to thrombophlebitis, therefore, group of lipid emulsions are carried out as a carrier of essential drugs.
Consumer Type Outlook:
Parenteral nutrition is a feasible option for adult and child patients with functional gastrointestinal tract or disorders requiring complete bowel rest that include certain stages of ulcerative colitis, intestinal obstruction, along with short bowel syndrome resulting from surgery. Severely ill people are often at an increased risk of malnutrition. Acute and chronic illness, trauma and inflammation induced stress-related catabolism, and drug-induced adverse effects may reduce appetite or increase nausea and vomiting especially in children. The prescribed levels of specific nutrients provided for the adult receiving parenteral nutrition should be based on a formal nutritional assessment recommended by healthcare professionals. Nutritional requirements should include disease specific needs based on patient type, that is adults, children and new born babies and factors to be considered include medical condition, nutritional status together with fluid restrictions and organ function.
Infants and children are likely to suffer from biochemical essential fatty acid deficiency within a week or two, if administered with a fat-free diet. Premature infants have a number of unique characteristics that affect the application and safety of parenteral nutrition. The consequences of malnutrition are extreme, critical and diverse, and can severely affect all organs in the body. Failure to provide adequate nutrition leads to ill health, which can lead to immune dysfunction, tangled physiological function and delayed wound healing especially in adult patients
End Use Outlook:
The hospitals end-use segment accounted for the largest revenue share in the global market in 2020, and is expected to continue to contribute the largest revenue share over the forecast period. This is due to large number of patient footfalls in hospitals and rapidly developing infrastructure to accommodate more patients. The clinics end-use segment is expected to register the highest revenue growth rate during the forecast period.
The North America market accounted for the largest revenue share in the global market in 2020, due to high research expenditures by the government of countries in the region, as well as private organizations operating in the healthcare sector, and collaborations between regulatory authorities, the medical device sector, and universities.
The Asia Pacific parenteral nutrition market is expected to register the highest revenue growth rate during the forecast period, owing to favorable government initiatives related to healthcare infrastructure development and reimbursement policies in countries in the region. Economic development in countries such as China, India, and Japan, and increasing government initiatives for development of healthcare infrastructure and implementation of reimbursement policies are factors supporting market growth.
Companies considered and profiled in the market report:
Baxter International Inc.; Grifols International S.A.; Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Hospira Inc., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical, Pfizer and Aculife (Nirlife). The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
In 2018, B. Braun launched Parenteral Nutrition 360 (PN360) program, this program included features of latest services and technology in its robust parenteral nutrition and compounding portfolio
In 2019, Baxter and ASPEN announced their collaboration to help reduce malnutrition through appropriate use of parenteral nutrition therapy through Smart PN. This collaboration played a critical role to minimize malnutrition and achieve better possible health outcomes
Segments covered in the report:
This report offers historical data points and forecasts and revenue growth at a global, regional, and country level, and provides analysis, industry trends, and consumption pattern details for each segment from 2018 to 2028. The global parenteral nutrition market report includes market size, market share, ongoing industry trends, market revenue or revenue share contributed by each regional market, and each of the segments. In addition, the report offers industry analysis in terms of revenue growth opportunities for existing as well as entry level players.
The report includes a detailed view of the global parenteral nutrition market, along with changing dynamics and trends, scenarios, recalls, detailed market and regional segmentation, regional landscape, analysis and evaluation or revenues and investments, and details of historical, current, and projected revenue. Also, recent trends, DROT, and related developments in the global parenteral nutrition market are included. Competitive landscape includes revenue share, financials, and various strategies adopted by key players in the market along with product offerings.
For the purpose of this report, Reports and Data has segmented the global parenteral nutrition market based on nutrient type, consumer type, end use, and region:
Parenteral Nutrition Market Report Scope
Segments covered By Nutrient Type Outlook, Consumer Type Outlook, End Use Outlook, Regional Outlook
By Nutrient Type Outlook
Single Dose Amino Acid Solution
Vitamins and Minerals
By Consumer Type Outlook
Children and New-born
By End Use Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119001/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: